Clinical Trials
27 trialsOpen-label Phase 2 Study of Avutometinib (RAF/MEK Clamp) in Combination With Defactinib (FAK Inhibitor) and Cetuximab in Patients With Unresectable, Anti-EGFR-Refractory Advanced Colorectal Cancer
M.D. Anderson Cancer Center
FOLICOLOR
University Hospital, Antwerp
Clinical Study on the First-line Treatment of Advanced Colorectal Cancer With Simultaneous Infusion of Levozolinate for Injection and 5-FU
Chinese PLA General Hospital
Assessment of the Dose Safety and Efficacy of Serine Combined With Fluorouracil Drugs
The First Affiliated Hospital of Xinxiang Medical College
A Phase 2 Study Evaluating the Safety and Efficacy of JS207 With or Without JS015 in Combination With Chemotherapy in Patients With Colorectal Cancer
Shanghai Junshi Bioscience Co., Ltd.
SUPβORT
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Chemokine and Co-stimulatory Molecule-modified Mesenchymal Stem Cells for the Treatment of Advanced Colorectal Cancer
Shanghai East Hospital
A Clinical Study of T3011 in Combination With Regorafenib in Patients With Advanced Colorectal Cancer
West China Hospital
Cetuximab in Combination With Dabrafenib and Tislelizumab in BRAF Mutated Treatment of Advanced Colorectal Cancer
Zhejiang Cancer Hospital
Fruquintinib Combined With Chemotherapy as Third-line /Third-line+ Treatment in Advanced Colorectal Cancer
Zhejiang Cancer Hospital
STREAM
National Cancer Institute, Naples
A Prospective Cohort Study of Advanced Colorectal Cancer Treated With Oxaliplatin and Irinotecan.
Sun Yat-sen University
Circulating Tumor DNA Guided Therapeutic Strategies for CRC Patients With Small Pulmonary Nodules
Fudan University
Efficacy, Safety and Exploratory Clinical Study of Bevacizumab Combined With Oxaliplatin and TAS-102 in First-line Treatment of Advanced Colorectal Cancer
The First Affiliated Hospital of Zhengzhou University
Anlotinib Combined With mXELIRI as Second-line Treatment of Advanced Colorectal Cancer
Guangzhou University of Traditional Chinese Medicine
Raltitrexed-based Chemotherapy Plus Bevacizumab in Retreated Patients With Advanced Colorectal Cancer
Jiangsu Cancer Institute & Hospital
A Study of Bevacizumab Plus XELOX/XELIRI for First-line Treatment in Unresectable Advanced Colorectal Cancer
Jiangsu Cancer Institute & Hospital
Evaluate the Efficacy of MEDI4736 in Immunological Subsets of Advanced Colorectal Cancer
Memorial Sloan Kettering Cancer Center
Surufatinib Combine With Immunotherapy and Chemotherapy for Second-line Treatment in Advanced Colorectal Cancer
Jiangsu Cancer Institute & Hospital
A-REPEAT
Hellenic Cooperative Oncology Group
Efficacy Analysis of Cetuximab Plus Irinotecan in Patients With Wild-type KRAS Without Regard to Epidermal Growth Factor Receptor (EGFR) Expressions
Asan Medical Center
DISTINCTIVE
Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente
Efficacy and Safety Evaluation of Traditional Chinese Medicine in the Treatment of Advanced Colorectal Cancer
Xiyuan Hospital of China Academy of Chinese Medical Sciences
A Pilot Study of PPX in Women With Metastatic Colorectal Cancer
University of Southern California
OXCE
Shanghai Jiao Tong University School of Medicine
Study of Nimotuzumab to Treat Colorectal Cancer
Peking University
High Dose Simplified Folfiri in Advanced Colorectal Cancer: a Multicentre Phase II Study
University Hospital, Ghent